Cargando…

A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes

Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Seal, Snehaa V., Henry, Mathilde, Pajot, Clémentine, Holuka, Cyrielle, Bailbé, Danielle, Movassat, Jamileh, Darnaudéry, Muriel, Turner, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168276/
https://www.ncbi.nlm.nih.gov/pubmed/35677049
http://dx.doi.org/10.3389/fimmu.2022.896179
_version_ 1784720969003171840
author Seal, Snehaa V.
Henry, Mathilde
Pajot, Clémentine
Holuka, Cyrielle
Bailbé, Danielle
Movassat, Jamileh
Darnaudéry, Muriel
Turner, Jonathan D.
author_facet Seal, Snehaa V.
Henry, Mathilde
Pajot, Clémentine
Holuka, Cyrielle
Bailbé, Danielle
Movassat, Jamileh
Darnaudéry, Muriel
Turner, Jonathan D.
author_sort Seal, Snehaa V.
collection PubMed
description Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes independent of obesity remains unclear. Goto-Kakizaki rats are a non-obese Type-2 diabetes model. The limited evidence available suggests that Goto-Kakizaki rats have a pro-inflammatory immune profile in pancreatic islets. Here we present a detailed overview of the adult Goto-Kakizaki rat immune system. Three converging lines of evidence: fewer pro-inflammatory cells, lower levels of circulating pro-inflammatory cytokines, and a clear downregulation of pro-inflammatory signalling in liver, muscle and adipose tissues indicate a limited pro-inflammatory baseline immune profile outside the pancreas. As Type-2 diabetes is frequently associated with obesity and adipocyte-released inflammatory mediators, the pro-inflammatory milieu seems not due to Type-2 diabetes per se; although this overall reduction of immune markers suggests marked immune dysfunction in Goto-Kakizaki rats.
format Online
Article
Text
id pubmed-9168276
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91682762022-06-07 A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes Seal, Snehaa V. Henry, Mathilde Pajot, Clémentine Holuka, Cyrielle Bailbé, Danielle Movassat, Jamileh Darnaudéry, Muriel Turner, Jonathan D. Front Immunol Immunology Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes independent of obesity remains unclear. Goto-Kakizaki rats are a non-obese Type-2 diabetes model. The limited evidence available suggests that Goto-Kakizaki rats have a pro-inflammatory immune profile in pancreatic islets. Here we present a detailed overview of the adult Goto-Kakizaki rat immune system. Three converging lines of evidence: fewer pro-inflammatory cells, lower levels of circulating pro-inflammatory cytokines, and a clear downregulation of pro-inflammatory signalling in liver, muscle and adipose tissues indicate a limited pro-inflammatory baseline immune profile outside the pancreas. As Type-2 diabetes is frequently associated with obesity and adipocyte-released inflammatory mediators, the pro-inflammatory milieu seems not due to Type-2 diabetes per se; although this overall reduction of immune markers suggests marked immune dysfunction in Goto-Kakizaki rats. Frontiers Media S.A. 2022-05-23 /pmc/articles/PMC9168276/ /pubmed/35677049 http://dx.doi.org/10.3389/fimmu.2022.896179 Text en Copyright © 2022 Seal, Henry, Pajot, Holuka, Bailbé, Movassat, Darnaudéry and Turner https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Seal, Snehaa V.
Henry, Mathilde
Pajot, Clémentine
Holuka, Cyrielle
Bailbé, Danielle
Movassat, Jamileh
Darnaudéry, Muriel
Turner, Jonathan D.
A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_full A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_fullStr A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_full_unstemmed A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_short A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes
title_sort holistic view of the goto-kakizaki rat immune system: decreased circulating immune markers in non- obese type 2 diabetes
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168276/
https://www.ncbi.nlm.nih.gov/pubmed/35677049
http://dx.doi.org/10.3389/fimmu.2022.896179
work_keys_str_mv AT sealsnehaav aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT henrymathilde aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT pajotclementine aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT holukacyrielle aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT bailbedanielle aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT movassatjamileh aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT darnauderymuriel aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT turnerjonathand aholisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT sealsnehaav holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT henrymathilde holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT pajotclementine holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT holukacyrielle holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT bailbedanielle holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT movassatjamileh holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT darnauderymuriel holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes
AT turnerjonathand holisticviewofthegotokakizakiratimmunesystemdecreasedcirculatingimmunemarkersinnonobesetype2diabetes